New drugs in psychiatry: focus on new pharmacological targets [version 1; referees: 3 approved]
The approval of psychotropic drugs with novel mechanisms of action has been rare in recent years. To address this issue, further analysis of the pathophysiology of neuropsychiatric disorders is essential for identifying new pharmacological targets for psychotropic medications. In this report, we det...
Main Authors: | Filippo Caraci, Gian Marco Leggio, Salvatore Salomone, Filippo Drago |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-03-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-397/v1 |
Similar Items
-
Recent advances in the understanding and management of bipolar disorder in adults [version 1; referees: 2 approved]
by: Janusz K. Rybakowski
Published: (2017-11-01) -
Recent advances in predicting responses to antidepressant treatment [version 1; referees: 2 approved]
by: Thomas Frodl
Published: (2017-05-01) -
Disinhibition, an emerging pharmacology of learning and memory [version 1; referees: 3 approved]
by: Hanns Möhler, et al.
Published: (2017-02-01) -
Fragile X syndrome and fragile X-associated disorders [version 1; referees: 2 approved]
by: Akash Rajaratnam, et al.
Published: (2017-12-01) -
Serotonin receptors in depression: from A to B [version 1; referees: 3 approved]
by: Katherine M. Nautiyal, et al.
Published: (2017-02-01)